Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Deruxtecan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,216,225Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    27/02/2026 CARBOGEN AMCIS AG
    Switzerland
    		 CARBOGEN AMCIS AG 305MF10037 MAAA-1162a 2023-03-23 2023-03-23 Hauptstrasse 171, CH-4416 Bubendorf, Switzerland
    27/02/2026 Lonza Inc & Lonza America Inc
    U.S.A
    		 Lonza AG 305MF10036 MAAA-1162a 2023-03-23 2023-03-23 Muenchensteiner strasse 38, CH-4002, Basel, Switzerland
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.